Xxera/openscience/retractions

Record #6401

The Phosphoinositide-Dependent Kinase-1 Inhibitor 2-Amino-N-[4-[5-(2-phenanthrenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]phenyl]-acetamide (OSU-03012) Prevents Y-Box Binding Protein-1 from Inducing Epidermal Growth Factor Receptor

K To, Y Zhao, H Jiang, K Hu, M Wang, J Wu, C Lee, D W Yokom, A L Stratford, U Klinge, P R Mertens, Ching Shih Chen, M Bally, D Yapp, Sandra E Dunn

Journal

Molecular Pharmacology

Publisher

ASPET: American Society for Pharmacology and Experimental Therapeutics

Original paper date

Aug 23, 2007

Original DOI

10.1124/mol.107.036111

Country

🇨🇦 Canada · 🇩🇪 Germany · 🇺🇸 United States

Institution

Laboratory for Oncogenomic Research, Department of Pediatrics, Child and Family Research Institute, University of British Columbia, Vancouver, British Columbia, Canada Laboratory for Oncogenomic Research, Departments of Pediatrics, Experimental Medicine, and Medical Genetics, Child and Family Research Institute, University of British Columbia, Vancouver, British Columbia, Canada · Applied Medical Engineering, Helmholtz Institute, RWTH Aachen University, Aachen, Germany · Departments of Nephrology and Clinical Immunology, University Hospital Aachen, RWTH Aachen, Aachen, Germany · Division of Medical Chemistry and Pharmacognosy, the Ohio State University, Columbus, Ohio · Department of Advanced Therapeutics, British Columbia Cancer Agency, Vancouver, British Columbia, Canada

Open access

No

Article type

Research Article

Broad categories

(BLS) Biology - Cellular (BLS) Biology - Molecular (BLS) Genetics (HSC) Medicine - Pharmacology

Notes from Retraction Watch

Sandra Dunn has institutional finding of misconduct; Ching Shih Chen has institutional finding of misconduct;

Citation lifecycle

How this paper is being cited

Pre-retraction

25

Same day

0

Post-retraction

6

% post-retraction

19.4%

~2.8 citations/yr before retraction · ~0.6 citations/yr after

— citing papers

Who is still citing this work

Loading…